Cryselle

— THERAPEUTIC CATEGORIES —
  • Contraception

Cryselle Generic Name & Formulations

General Description

Norgestrel 0.3mg, ethinyl estradiol 30mcg (21 tabs); inert (7 tabs).

Pharmacological Class

Progestin + estrogen.

How Supplied

Packs—6

Manufacturer

Cryselle Indications

Indications

Oral contraception.

Cryselle Dosage and Administration

Adult

1 tab daily for 28 days; repeat.

Children

Not applicable.

Cryselle Contraindications

Contraindications

Thrombophlebitis or thromboembolic disorders. Cerebral vascular or coronary artery disease. Breast or other estrogen-dependent neoplasms. Undiagnosed abnormal genital bleeding. Cholestatic jaundice of pregnancy or jaundice with prior OC use. Hepatic adenoma or carcinoma. Pregnancy (Cat.X).

Cryselle Boxed Warnings

Boxed Warning

Cigarette smoking increases risk of serious cardiovascular events.

Cryselle Warnings/Precautions

Warnings/Precautions

Increased risk of cardiovascular events (eg, MI, stroke, VTE). Smokers >35yrs of age: not recommended. Uncontrolled hypertension. Hypertriglyceridemia. Discontinue if jaundice, visual disturbances, migraine or other severe headaches occur. Do regular complete physical exams. May need barrier contraception with Sunday starts or postpartum use (see full labeling). Nursing mothers: not recommended.

Cryselle Pharmacokinetics

See Literature

Cryselle Interactions

Interactions

Antagonized by hepatic enzyme inducing drugs (eg, rifampin, griseofulvin, St. John's wort), possibly others. May affect measurement of sex hormone-binding globulin levels.

Cryselle Adverse Reactions

Adverse Reactions

Hypertension, nausea, vomiting, breakthrough bleeding, amenorrhea, transient delay of ovulation after discontinuation, edema, chloasma, mastodynia, headache, intolerance to contact lenses. Increased risk of gallbladder disease, thromboembolic disorders.

Cryselle Clinical Trials

See Literature

Cryselle Note

Not Applicable

Cryselle Patient Counseling

See Literature